Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Prime Medicine, Inc. | Member of 10% Group | Common Stock | 3.2M | $20M | $6.25 | Feb 20, 2024 | By GV 2023, L.P. |
Verve Therapeutics, Inc. | Member of 10% Group | Common Stock | 1.8M | $18M | $10.00 | Dec 1, 2023 | By GV 2023, L.P. |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PRME | Prime Medicine, Inc. | Feb 20, 2024 | 0 | $0 | 3 | Feb 29, 2024 | Member of 10% Group |
VERV | Verve Therapeutics, Inc. | Dec 1, 2023 | 0 | $0 | 3 | Dec 5, 2023 | Member of 10% Group |